Guardian Unlimited
Go to:  
Guardian UnlimitedThe Guardian
Home UK Business Online World dispatch The Wrap Weblog Talk Search
The Guardian World News guide Arts Special reports Columnists Audio Help Quiz

Business
 
  Search this site






  In this section
Strong pound blamed for record trade deficit

Equitable directors snub report into losses by savers

Barclays' insurance hideaway

ITV directors in struggle for survival

CBI cries foul over UN human rights code

Budgetary largesse is a spent force

Carphone buys into Spanish telecoms

Red tape barometer attacked

Buffett keeps out of the dollar

Boots plans fail to impress

Desmond quits Telegraph auction

Pentagon warns British firms

Goldman trial told 'forgery rife'

Sainsbury's decline deepens

Insolvency chief backs reforms

GSK offers to mend its bad ways

Red faces at Credit Suisse

Jarvis cleared of rail fraud

'No-frills decline' in fact a rise

Profit surge boosts hope of recovery

Raffarin pressed to stay neutral

EU insists on right to subsidise farming

Mobile firms seek BT's favour

Listen hard: can you hear those bubbles bursting?

Made to measure for Dawnay

The benign buccaneer


Inquiry into Eli Lilly's practices

David Teather in New York
Friday March 26, 2004
The Guardian


Eli Lilly, the US pharmaceutical firm, yesterday said US prosecutors were investigating the company's marketing practices for certain of its best selling
ADVERTISEMENT
drugs, including the antidepressant Prozac.

The company said the US attorney in its home state of Pennsylvania had informed it of the inquiry in the past few days.

An Eli Lilly spokeswoman said the company understood the investigation was focused on Prozac and two other products, Evista, which fights osteoporosis, and Zyprexa, the world's leading schizophrenia medicine. Zyprexa was the company's highest selling product last year, generating revenues of $4.3bn.

Eli Lilly has been under investigation by the US department of justice since 2002 for its methods of marketing Evista to doctors. The justice department issued a second subpoena for documents related to Evista in July.

Pennsylvania officials recently filed a lawsuit against 13 drug companies, alleging that they offered doctors kickbacks for prescribing.

Special reports
Medicine and health

Useful links
British Medical Association
Department of Health
General Medical Council
Health on the Net Foundation
Institute of Cancer Research
Medical Research Council
NHS Direct
World Health Organisation




Printable version | Send it to a friend | Save story

 
 



UP

Guardian Unlimited Guardian Newspapers Limited 2004